Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling

Disease Markers

Volumn 30, Issue 1, 2011, Pages 1-17

  Sipos, Ferenc ^a   Galamb, Orsolya ^b   Wichmann, Barnabás ^a   Krenács, Tibor ^a   Tóth, Kinga ^a   Leiszter, Katalin ^a   Mzes, Györgyi ^a   Zágoni, Tamás ^a   Tulassay, Zsolt ^a,b   Molnár, Béla ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

blood; gene expression profile; IBD; screening; tissue microarray

Indexed keywords

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DIVERTICULITIS; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC COLITIS; MALE; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

EID: 79955122823     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2011/756290     Document Type: Article

References (74)

1. T. Ahmad, A. Armuzzi, M. Bunce, K. Mulcahy-Hawes, S.E. Marshall, T.R. Orchard, J. Crawshaw, O. Large, A. de Silva, J.T. Cook, M. Barnardo, S. Cullen, K.I. Welsh and D.P. Jewell, The molecular classification of the clinical manifestations of Crohn's disease, Gastroenterology 122 (2002), 854-866. (Pubitemid 34267267)
2. D.K. Bonen and J.H. Cho, The genetics of inflammatory bowel disease, Gastroenterology 124 (2003), 521-536. (Pubitemid 36169267)
3. S. Brand, K. Hofbauer, J. Dambacher, F. Schnitzler, T. Staudinger, S. Pfennig, Seiderer J.C. Tillack, A. Konrad, B. Göke, T. Ochsenkühn and P. Lohse, Increased expression of the chemokine fractalkine in Crohn's disease and associa-tion of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype, Am J Gastroenterol 101 (2006), 99-106. (Pubitemid 43381715)
4. O.H. Nielsen, B. Vainer, S.M. Madsen, J.B. Seidelin and N.H. Heegaard, Established and emerging biological activity mark-ers of inflammatory bowel disease, Am J Gastroenterol 95 (2000), 359-367. (Pubitemid 30106162)
5. M.T. Abreu, K.D. Taylor, Y.C. Lin, T. Hang, J. Gaiennie, CJ. Landers, E.A. Vasiliauskas, L.Y. Kam, M. Rojany, K.A. Papadakis, J.I. Rotter, S.R. Targan and H. Yang, Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease, Gastroenterology 123 (2002), 679-688. (Pubitemid 34977073)
6. R.H. Duerr, Update on the genetics of inflammatory bowel disease, J Clin Gastroenterol 37 (2003), 358-367. (Pubitemid 37296163)
7. J.R. Cummings, R.M. Cooney, G. Clarke, J. Beckly, A. Geremia, S. Pathan, L. Hancock, C. Guo, L.R. Cardon and D.P Jewell, The genetics of NOD-like receptors in Crohn's disease, Tissue Antigens 76 (2010), 48-56.
8. V. Andersen, E. Nimmo, H.B. Krarup, H. Drummond, J. Chris-tensen, G.T. Ho, M. Ostergaard, A. Ernst, C. Lees, B.A. Ja-cobsen, J. Satsangi and U. Vogel, Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study, Inflamm Bowel Dis (2010), in press. (Epub: 2010. Aug. 27.)
9. J. Mwinyi, C. Wenger, J.J. Eloranta and G.A. Kullak-Ublick, Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients, World J Gastroenterol 16 (2010), 3888-3896.
10. H. Ban, A. Andoh, H. Imaeda, A. Kobori, S. Bamba, T. Tsu-jikawa, M. Sasaki, Y. Saito and Y. Fujiyama, The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflamma-tory bowel disease, J Gastroenterol (2010), in press. (Epub: 2010. Apr. 15.)
11. P.L. Lakatos, L. Lakatos, F. Szalay, C. Willheim-Polli, C. Os-terreicher, Z. Tulassay, T. Molnar, W. Reinisch, J. Papp, G. Mozsik and P. Ferenci, Hungarian IBD Study Group, Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian pa-tients with Crohn's disease: phenotype-genotype correlations, World J Gastroenterol 11 (2005), 1489-1495. (Pubitemid 40468084)
12. M. Pierik, S. Joossens, K. Van Steen, N. Van Schuerbeek, R. Vlietinck, P. Rutgeerts and S. Vermeire, Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases, Inflamm Bowel Dis 12 (2006), 1-8. (Pubitemid 43032444)
13. K. Geboes, Is histology useful forthe assessment ofthe effica-cy of immunosuppressive agents in IBD and if so, how should it be applied?, Acta Gastroenterol Belg 67 (2004), 285-289. (Pubitemid 39486934)
14. CN. Bernstein and A. Nabalamba, Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study, Am J Gastroenterol 101 (2006), 110-118. (Pubitemid 43381717)
15. E. Gorgun, F.H. Remzi, E. Manilich, M. Preen, B. Shen and V.W. Fazio, Surgical outcome in patients with primary scle-rosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study, Surgery 138 (2005), 631-637.
16. G. Ḿúzes, Possible role ofmucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases, Orv Hetil 144 (2003), 1441-1446.
17. A.J. Grant, PF. Lalor, M. Salmi, S. Jalkanen and D.H. Adams, Homing ofmucosal lymphocytes to the liver in the pathogen-esis of hepatic complications of inflammatory bowel disease, Lancet 359 (2002), 150-157. (Pubitemid 34112549)
18. R. J. Mora, Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids, Inflamm Bowel Dis 14 (2008), 275-289.
19. M. Neuman, Immune dysfunction in inflammatory bowel dis-ease, Transl Res 149 (2007), 173-186. (Pubitemid 46442010)
20. L.M. Staudt and P.O. Brown, Genomic views ofthe immune system, Annu Rev Immunol 18 (2000), 829-859. (Pubitemid 30365399)
21. NJ. Olsen, J.H. Moore and TM. Aune, Gene expression sig-natures for autoimmune disease in peripheral blood mononu-clear cells, Arthritis Res Ther 6 (2004), 120-128. (Pubitemid 38735668)
22. F. Wu, T. Dassopoulos, L. Cope, A. Maitra, S.R. Brant, M.L. Harris, TM. Bayless, G. Parmigiani and S. Chakravarti, Genome-wide gene expression differences in Crohn's disease andulcerative colitis from endoscopic pinchbiopsies: insights into distinctive pathogenesis, Inflamm Bowel Dis 13 (2007), 807-821. (Pubitemid 47203859)
23. O. Galamb, F. Sipos, E. Dinya, S. Spisák, Z. Tulassay and B. Molnár, mRNA expression, functional profiling and multivari-ate classification of colon biopsy specimen by cDNA overall glass microarray, W J Gastroenterol 12 (2006), 6998-7006. (Pubitemid 44834891)
24. CM. Costello, N. Mah, R. Häsler, P. Rosenstiel, G.H. Waet-zig, A. Hahn, T. Lu, Y. Gurbuz, S. Nikolaus, M. Albrecht, J. Hampe, R. Lucius, G. Klöppel, H. Eickhoff, H. Lehrach, T. Lengauer and S. Schreiber, Dissection of the inflamma-tory bowel disease transcriptome using genome-wide cDNA microarrays, PLo SMed2 (2005), e199.
25. C. Csillag, O.H. Nielsen, R. Borup, F.C. Nielsen and J. Olsen, Clinical phenotype and gene expression profile in Crohn's disease, Am J Physiol Gastrointest Liver Physiol 292 (2007), G298-G304. (Pubitemid 46091632)
26. CF. Flach, A. Eriksson, E. Jennische, S. Lange, C. Gunnerek and I. Lönnroth, Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening, Inflamm Bowel Dis 12 (2006), 837-842. (Pubitemid 44352710)
27. J. Guzman, J.G. Yu, Z. Suntres, A. Bozarov, H. Cooke, N. Javed, H. Auer, J. Palatini, H.H. Hassanain, A.J. Cardounel, A. Javed, I.Grants, J.E. Wunderlich and F.L. Christofi, ADOA3R as atherapeutic target in experimental colitis: proof by validat-ed high-density oligonucleotide microarray analysis, Inflamm Bowel Dis 12 (2006), 766-789. (Pubitemid 44253762)
28. S. Heimerl, C. Moehle, A. Zahn, A. Boettcher, W. Stremmel, T. Langmann and G. Schmitz, Alterations in intestinal fatty acid metabolism in inflammatory bowel disease, Biochem Biophys Acta 1762 (2006), 341-350. (Pubitemid 43172850)
29. T. Langmann, C. Moehle, R. Mauerer, M. Scharl, G. Liebisch, A. Zahn, W. Stremmel and G. Schmitz, Loss ofdetoxification in inflammatory bowel disease: dysregulation ofpregnane X receptor target genes, Gastroenterology 127 (2004), 26-40. (Pubitemid 38962271)
30. I.C. Lawrance, C. Fiocchi and S. Chakravarti, Ulcerative col-itis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes, Hum Mol Genet 10 (2001), 445-456. (Pubitemid 32181667)
31. P. von Stein, R. Lofberg, N.V. Kuznetsov, A.W. Gielen, J.O. Persson, R. Sundberg, K. Hellstrom, A. Eriksson, R. Befrits, A. Ost and O.D. von Stein, Multigene analysis can discrimi-nate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome, Gastroenterology 134 (2008), 1869-1881. (Pubitemid 351790741)
32. B.K. Dieckgraefe, D.L. Crimmins, V. Landt, C. Houchen, S. Anant, R. Porche-Sorbet and J.H. Ladenson, Expression ofthe regenerating gene family in inflammatory bowel disease mu-cosa: Reg I alpha upregulation, processing, and antiapoptotic activity, J Investig Med 50 (2002), 421-434. (Pubitemid 35278683)
33. M.E. Burczynski, R.L. Peterson, N.C. Twine, K.A. Zuberek, BJ. Brodeur, L. Casciotti, V. Maganti, PS. Reddy, A. Strahs, F. Immermann, W. Spinelli, U. Schwertschlag, A.M. Slager, M.M. Cotreau and A.J. Dorner, Molecular classification of Crohn's disease and ulcerative colitis patients using transcrip-tional profiles in peripheral blood mononuclear cells, J Mol Diagn 8 (2006), 51-61. (Pubitemid 43257434)
34. E.E. Mannick, J.C. Bonomolo, R. Horswell, J.J. Lentz, M.S. Serrano, A. Zapata-Velandia, M. Gastanaduy, J.L. Himel, S.L. Rose, J.N. Udall, CA. Hornick and Z. Liu, Gene expression in mononuclear cells from patients with inflammatory bowel disease, Clin Immunol 112 (2004), 247-257. (Pubitemid 39078700)
35. Y. Yagi, A. Andoh, A. Ogawa, S. Bamba, T. Tsujikawa, M. Sasaki, K. Mitsuyama and Y Fujiyama, Microarray analysis ofleukocytapheresis-induced changes in gene expression pat-terns of peripheral blood mononuclear cells in patients with ulcerative colitis, Ther Apher Dial 11 (2007), 331-336. (Pubitemid 47383401)
36. The Tumor Analysis Best Practices Working Group, Expres-sion profiling-best practices for data generation and interpre-tation in clinical trials, (Guidelines), Nat Rev Genet 5 (2004), 229-237.
37. O. Galamb, B. Györffy, F. Sipos, S. Spisák, A.M. Németh, P. Miheller, Z. Tulassay, E. Dinya and B. Molnár, Inflammation, adenoma and cancer: objective classification ofcolon biopsy specimens with gene expression signature, Dis Markers 25 (2008), 1-16.
38. V. Tusher, R. Tibshirani and G. Chu, Significance analysis of microarrays applied to transcriptional responses to ionizing radiation, Proc Natl Acad Sci USA 98 (2001), 5116-5121. (Pubitemid 32397092)
39. R. Tibshirani, T. Hastie, B. Narasimhan and G. Chu, Diag-nosis of multiple cancer types by shrunken centroids of gene expression, Proc Natl Acad Sci USA 99 (2002), 6567-6572. (Pubitemid 34526173)
40. R Development Core Team, A language and environment for statistical computing, R Foundation for Statistical Comput-ing, Vienna, Austria, 2007, ISBN3-900051-07-0. Available at http://www. R-proj ect. org.
41. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang and J. Zhang, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol 5 (2004), R80.
42. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele and CT. Wittwer, The MIQE guidelines: minimum information for publication ofquantitative real-time PCR experiments, Clin Chem 55 (2009), 611-622.
43. J. Dabek, A. Kulach, T. Wilczok, U. Mazurek, D. Jakubows-ki and Z. Gasior, Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X, Inflammation 30 (2007), 125-129. (Pubitemid 46985777)
44. A. Komatsuda, H. Wakui, K. Iwamoto, M. Togashi, N. Maki, R. Masai, T. Hatakeyama and K. Sawada, Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus, Clinical Immunology 125 (2007), 26-29. (Pubitemid 47374538)
45. G.A. Bonaterra, W. Hildebrandt, A. Bodens, R. Sauer, K.A. Dugi, H.P. Deigner, D. Turcanu, H. Heinle, W. Dröge, J. Metz and R. Kinscherf, Increased gene expression of scavenger receptors and proinflammatory markers in peripheral blood mononuclear cells of hyperlipidemic males, J Mol Med 85 (2007), 181-190. (Pubitemid 46183616)
46. L. Herszényi, F. Sipos, O. Galamb, N. Solymosi, I. Hritz, P. Miheller, L. Berczi, B. Molnár and Z. Tulassay, Ma-trix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia- adenocarcinoma sequence of the colon, Pathol Oncol Res 14 (2008), 31-37.
47. Zh. Mihaylova, V. Ludovini, V. Gregorg, I. Floriani, L. Pisto-la, F. Toffaneti, M. Ferraldeschi, A. Spreafico, G.L. Ceresoli, M. Bellet, S. Darwish, M. Tonato and J. Raynov, Serum level changes of matrix metalloproteinases 2 and 9, vascular en-dothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients, JBUON 12 (2007), 105-111. (Pubitemid 46824679)
48. E. Andersen-Nissen, K.D. Smith, R. Bonneau, R.K. Strong and A. Aderem, A conserved surface on Toll-like receptor 5 recognizesbacterialflagellin, J Exp Med204(2007), 393-403. (Pubitemid 46294554)
49. F. A. Carvalho, N. Barnich, P. Sauvanet, C. Darcha, A. Gelot and A. Darfeuille-Michaud, Crohn's disease-associated Es-cherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin, Inflamm Bowel Dis 14 (2008), 1051-1060.
50. L.W. Duck, M.R. Walter, J. Novak, D. Kelly, M. Tomasi, Y. Cong and CO. Elson, Isolation offlagellated bacteria impli-cated in Crohn's disease, Inflamm Bowel Dis 13 (2007), 1191-1201. (Pubitemid 47597766)
51. G. Heuschen, C. Leowardi, U. Hinz, F. Autschbach, A. Stall-mach, C. Herfarth andU.A. Heuschen, Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa ofulcerative colitis patients, Int J Colorectal Dis 22 (2007), 293-301. (Pubitemid 46071107)
52. M.J. Lodes, Y. Cong, CO. Elson, R. Mohamath, C. J. Landers, S.R. Targan, M. Fort andR.M. Hershberg, Bacterial flagellin is a dominant antigen in Crohn disease, J Clin Invest 113 (2004), 1296-1306. (Pubitemid 39069929)
53. A.T Gewirtz, M. Vijay-Kumar, S.R. Brant, R.H. Duerr, D.L. Nicolae and J.H. Cho, Dominant-negative TLR5 polymor-phism reduces adaptive immune response to flagellin and neg-atively associates with Crohn's disease, Am J Physiol Gas-trointest Liver Physiol 290 (2006), G1157-G1163. (Pubitemid 43788297)
54. M.G. Netea, G. Ferwerda, DJ. de Jong, T. Jansen, L. Jacobs, M. Kramer, TH. Naber, J.P Drenth, S.E. Girardin, BJ. Kullberg, GJ. Adema and J.W. Van der Meer, Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways forthe induction ofcytokine release, J Immunol 174 (2005), 6518-6523. (Pubitemid 40663847)
55. F. Sipos, G. G. Ḿúzes, O. Galamb, S. Spisák, T. Krenács, K. Tóth, Z. Tulassay and B. Molnár, The possible role of isolated lymphoidfollicles incolonic mucosal repair, Pathol Oncol Res 16 (2010), 11-18.
56. D. Giorgi, J.-P Bernard, S. Rouquier, J. Iovanna, H. Sarles and J.C Dagorn, Secretory pancreatic stone protein messen-ger RNA: nucleotide sequence and expression in chronic cal-cifying pancreatitis, J Clin Invest 84 (1989), 100-106. (Pubitemid 19170100)
57. H. Sarles, J.C Dagorn, D. Giorgi and J.P Bernard, Renaming pancreatic stone protein as 'lithostathine', Gastroenterology 99 (1990), 900-901. (Pubitemid 20243397)
58. J.M. Verdier, B. Dussol, P. Casanova, M. Daudon, P. Dupuy, P. Berthezene, R. Boistelle, Y Berland and J.C Dagorn, Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of Ca CO(3) crystal growth, Europ J Clin Invest 22 (1992), 469-474.
59. H. Fukui, F. Franceschi, R.L. Penland, T. Sakai, A.R. Sepulve-da, T. Fujimori, A. Terano, T. Chiba and R.M. Genta, Effects of Helicobacter pylori infection on the link between regener-ating gene expression and serum gastrin levels in Mongolian gerbils, Lab Invest 83 (2003), 1777-1786. (Pubitemid 38018541)
60. M. Asahara, S. Mushiake, S. Shimada, H. Fukui, Y Kinoshita, C. Kawanami, T. Watanabe, S. Tanaka, A. Ichikawa, Y. Uchiyama, Y Narushima, S. Takasawa, H. Okamoto, M. Tohyama and T. Chiba, Reg gene expression is increased in rat gastric enterochromaffin-like cells following water-immersion stress, Gastroenterology 111 (1996), 45-55. (Pubitemid 26226882)
61. C. Kawanami, H. Fukui, Y Kinoshita, H. Nakata, M. Asahara, Y. Matsushima, K. Kishi and T. Chiba, Regenerating gene ex-pression in normal gastric mucosa and indomethacin-induced mucosal lesions ofthe rat, J Gastroenterol 32 (1997), 12-18. (Pubitemid 27075875)
62. Y Satomura, N. Sawabu, I. Mouri, O. Yamakawa, H. Watanabe, Y Motoo, T. Okai, T. Ito, K. Kaneda and H. Okamoto, Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked im-munosorbent assay, J Gastroenterol 30 (1995), 643-650.
63. R. Graf, M. Schiesser, A. Lüssi, P. Went, G.A. Scheele and D. Bimmler, Coordinate regulation ofsecretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis, J Surg Res 105 (2002), 136-144. (Pubitemid 34765320)
64. S. Shinozaki, T. Nakamura, M. Iimura, Y. Kato, B. Iizuka, M. Kobayashi and N. Hayashi, Upregulation of Reg 1a and GW112 in the epithelium of inflamed colonic mucosa, Gut 48 (2001), 623-629. (Pubitemid 32378580)
65. F. Sipos, B. Molnár, T. Zágoni, L. Berczi and Z. Tulassay, Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bow-el diseases: ulcerative colitis shows specific p53-and EGFR expression alterations, Dis Colon Rectum 48 (2005), 775-786. (Pubitemid 40880726)
66. P. Garg, M. Vijay-Kumar, L. Wang, A.T. Gewirtz, D. Merlin and S.V. Sitaraman, Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis, Am J Physiol Gastrointest Liver Physiol 296 (2009), G175-G184.
67. Q. Gao, MJ. Meijer, FJ. Kubben, CF. Sier, L. Kruidenier, W. van Duijn, M. van den Berg, R.A. van Hogezand, CB. Lamers and H.W. Verspaget, Expression ofmatrixmetalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases, Dig Liver Dis 37 (2005), 584-592. (Pubitemid 44356072)
68. B.C. McKaig, D. McWilliams, S.A. Watson and Y.R. Mahida, Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intesti-nal myofibroblasts in inflammatory bowel disease, Am JPathol 162 (2003), 1355-1360. (Pubitemid 36350679)
69. K.P. Schlingmann, S. Weber, M. Peters, L. Niemann Nejsum, H. Vitzthum, K. Klingel, M. Kratz, E. Haddad, E. Ristoff, D. Dinour, M. Syrrou, S. Nielsen, M. Sassen, S. Waldegger, H.W. Seyberth and M. Konrad, Hypomagnesemia with sec-ondary hypocalcemia is caused by mutations in TRPM6, a new member ofthe TRPM gene family, Nature Genet 31 (2002), 166-170.
70. R.Y Walder, D. Landau, P. Meyer, H. Shalev, M. Tsolia, Z. Borochowitz, M.B. Boettger, G.E. Beck, R.K. Englehardt, R. Carmi and V.C. Sheffield, Mutation ofTRPM6 causes familial hypomagnesemiawithsecondaryhypocalcemia, Nature Genet 31 (2002), 171-174.
71. B. Nilius, G. Owsianik, T. Voets and J.A. Peters, Transient Receptor Potential Cation Channels in Disease, Physiol Rev 87 (2007), 165-217. (Pubitemid 46207713)
72. S.R. Levine, TJ. Crowley and H.A. Hai, Hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in a nondigitalized noncardiac patient, Chest 81 (1982), 244-247. (Pubitemid 12165562)
73. M.A. La Sala, F. Lifshitz, M. Silverberg, R.A. Wapnir and E. Carrera, Magnesium metabolism studies in children with chronic inflammatory disease of the bowel, J Pediatr Gastroenterol Nutr 4 (1985), 75-81. (Pubitemid 15061184)
74. A.E. M'Koma, K. Lindquist and L. Liljeqvist, Biochemical laboratory data in patients before and after restorative proc-tocolectomy. A study on 83 patients with a follow-up of 36 months, Ann Chir 48 (1994), 525-534. (Pubitemid 24287096)